Priscilla Pemu
Overview
Explore the profile of Priscilla Pemu including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
33
Citations
601
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Spikes T, Thorpe Jr R, Michopoulos V, Wharton W, Pelkmans J, Dunbar S, et al.
J Am Heart Assoc
. 2025 Feb;
14(5):e036498.
PMID: 39996445
Background: Psychosocial stressors such as childhood trauma have been associated with an increased risk of hypertension. The impact of childhood trauma on vascular dysfunction in Black adults remains less clear....
2.
Mills K, Figueroa F, Knight R, Ekpo E, Lee L, Baldo L, et al.
Clin Transl Gastroenterol
. 2025 Jan;
PMID: 39878425
Introduction: To assess strategies for optimizing participation of underserved minorities in a blood-based early colorectal cancer detection test study (PREEMPT CRC; NCT04369053) at a hospital serving primarily Black individuals. Methods:...
3.
Pemu P, Maxwell C, Singh R, Vadgama J, Arjumand S, Armstrong L
J Natl Med Assoc
. 2024 Oct;
116(5):566-568.
PMID: 39414489
No abstract available.
4.
Erlandson K, Geng L, Selvaggi C, Thaweethai T, Chen P, Erdmann N, et al.
Ann Intern Med
. 2024 Aug;
177(9):1209-1221.
PMID: 39133923
Background: There are currently no validated clinical biomarkers of postacute sequelae of SARS-CoV-2 infection (PASC). Objective: To investigate clinical laboratory markers of SARS-CoV-2 and PASC. Design: Propensity score-weighted linear regression...
5.
Igwe J, Wangdak Yuthok T, Cruz E, Mueller A, Lan R, Brown-Johnson C, et al.
J Am Heart Assoc
. 2023 Dec;
12(24):e030042.
PMID: 38108253
The United States witnessed a nearly 4-fold increase in personal health care expenditures between 1980 and 2010. Despite innovations and obvious benefits to health, participants enrolled in clinical trials still...
6.
Rice E, Lan R, Nunes J, Shah R, Clark K, Periyakoil V, et al.
J Am Heart Assoc
. 2023 Nov;
12(22):e030209.
PMID: 37947088
No abstract available.
7.
Drawz P, Lenoir K, Rai N, Rastogi A, Chu C, Rahbari-Oskoui F, et al.
Clin J Am Soc Nephrol
. 2023 Oct;
19(2):213-223.
PMID: 37883184
Background: Intensive BP lowering in the Systolic Blood Pressure Intervention Trial (SPRINT) produced acute decreases in kidney function and higher risk for AKI. We evaluated the effect of intensive BP...
8.
Idris M, Fitzsimmons W, Pemu P
Ther Innov Regul Sci
. 2023 Oct;
58(1):175-183.
PMID: 37872439
Background: Health care inequity includes the lack of adequate representation of various populations in clinical trials. Government, academic and industry organizations have highlighted these issues and committed to actions to...
9.
Horwitz L, Thaweethai T, Brosnahan S, Cicek M, Fitzgerald M, Goldman J, et al.
PLoS One
. 2023 Jun;
18(6):e0286297.
PMID: 37352211
Importance: SARS-CoV-2 infection can result in ongoing, relapsing, or new symptoms or other health effects after the acute phase of infection; termed post-acute sequelae of SARS-CoV-2 infection (PASC), or long...
10.
Thaweethai T, Jolley S, Karlson E, Levitan E, Levy B, McComsey G, et al.
JAMA
. 2023 Jun;
329(22):1934-1946.
PMID: 37278994
Importance: SARS-CoV-2 infection is associated with persistent, relapsing, or new symptoms or other health effects occurring after acute infection, termed postacute sequelae of SARS-CoV-2 infection (PASC), also known as long...